Enveric Biosciences Inc vs MiniMed Group Inc. Common Stock — how do they compare? Enveric Biosciences Inc trades at $1.48 (market cap $6.80M), while MiniMed Group Inc. Common Stock trades at $19.61 (market cap $5.57B). The key difference: MiniMed Group Inc. Common Stock is far larger — about 819.1× Enveric Biosciences Inc's market cap, and MiniMed Group Inc. Common Stock is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Enveric Biosciences Inc for 14 Days and MiniMed Group Inc. Common Stock for 1 Days on average.
| ENVB | MMED | |
|---|---|---|
Market Cap | $6.80M | $5.57B |
Volume | 64,867 | 23,336,073 |
Sector | Health | Health |
52-Week High | $10.80 | $23.84 |
52-Week Low | $1.27 | $10.80 |
Typical Hold Time | 14 Days | 1 Days |
Enterprise Value | -$1.49M | $5.37B |
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.45, down 3.01% on the day, with a bearish technical signal driven by moving averages. The company reported no revenue in 2025 and a net loss of $8.77 million, though it has consistently beaten quarterly EPS expectations. Recent positive developments include a new U.S. patent allowance for its non-hallucinogenic mescaline derivatives and participation in investor conferences.
The outlook is mixed; analyst consensus is 75% buy with strong earnings beats, but high negative ROE/ROA and operational cash burn pose significant risks. Investment opportunity hinges on successful drug development, while key risks include funding needs and clinical trial outcomes.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →MiniMed develops, manufactures, and markets diabetes-management technologies. Its products include insulin-delivery systems, continuous glucose monitors, smart insulin pens, and related software.
Read more on MMED →